Medical Condition News

RSS

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

ViroPharma Incorporated and Halozyme Therapeutics announced today that ViroPharma has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme, in subjects with hereditary angioedema.

14 Sep 2011

OBT, Seattle Genetics form strategic collaboration to discover novel ADCs for cancer

Seattle Genetics, Inc. and Oxford BioTherapeutics today announced that they have formed a strategic collaboration to jointly discover novel antibody-drug conjugates (ADCs) for cancer.

14 Sep 2011

Genetic variant associated with increased long-term mortality risk after coronary artery bypass graft procedure

Duke University Medical Center researchers have found a genetic variant that seems to be associated with lower five-year survival after a coronary artery bypass.

14 Sep 2011

Practical NCD guide for everyone to improve their health

The world's health professions have launched an easy-to-use, practical guide to help individuals and their health professionals reduce the risk of noncommunicable diseases (NCDs) - conditions which currently account for 60% of global deaths.

14 Sep 2011

USU, HJF to host 'The TBI Spectrum' symposium on Sept. 22

New Jersey Congressman and former Philadelphia Eagles offensive lineman Jon Runyan and Army Vice Chief of Staff General Peter Chiarelli will deliver keynote addresses at the fourth USU-HJF Military Medicine Symposium, "The TBI Spectrum," Sept. 22, 2011.

14 Sep 2011

Acceleron commences ACE-536 Phase 1 clinical trial in anemia

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.

14 Sep 2011

Henry Ford study identifies 23 microRNAs for laryngeal cancer

A Henry Ford Hospital study has identified 23 microRNAs for laryngeal cancer, a discovery that could yield new insight into what causes certain cells to grow and become cancerous tumors in the voice box.

14 Sep 2011

African-Americans have higher risk of high blood pressure earlier

...

13 Sep 2011

High cholesterol and Alzheimer's disease

New research suggests that high cholesterol levels could boost the risk of Alzheimer's disease by creating more brain-clogging bits known as plaque. Researchers however didn't find any link between high cholesterol and tangles, which also clog the brain in those with Alzheimer's.

13 Sep 2011

A squirt of insulin up the nose for prevention of Alzheimer’s disease

Researchers have noted in a small pilot study that squirting insulin deep into the nose where it travels to the brain might hold early Alzheimer’s disease at bay. At present there are no effective ways to prevent or delay the progress of Alzheimer’s. More than 5.4 million Americans and 35 million people worldwide have Alzheimer's, the most common form of dementia.

13 Sep 2011

House Research Institute launches hearing loss awareness campaign

House Research Institute has launched a three month nationwide outreach campaign to support the institute's educational initiative It's How You Listen That Counts.

13 Sep 2011

Open Access publishing likely to become preferred option for cancer researchers

With researchers, authors and funders challenging the traditional journal publishing model, Open Access (OA) publishing is likely to become the preferred option, suggests a paper published in ecancermedicalscience.

13 Sep 2011

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

Bayer HealthCare announced today that the company will present data on several of its investigational compounds at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

13 Sep 2011

FDA announces organizational changes within CDER's Office of Oncology Drug Products

Today, the U.S. Food and Drug Administration announced organizational changes within the office responsible for reviewing all drug and biologic applications for cancer therapies.

13 Sep 2011

New drug combination may treat two aggressive cancers

Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings are published in Cancer Cell on September 13, 2011.

13 Sep 2011

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

Delcath Systems, Inc. announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany.

13 Sep 2011

ADI releases World Alzheimer Report 2011

The World Alzheimer Report 2011, released today by Alzheimer's Disease International (ADI), shows that there are interventions that are effective in the early stages of Alzheimer's disease, some of which may be more effective when started earlier, and that there is a strong economic argument in favor of earlier diagnosis and timely intervention.

13 Sep 2011

Researchers use MRI and PET/CT to assess safety, efficacy of heart drug dalcetrapib

Researchers from Mount Sinai School of Medicine have for the first time used several imaging techniques to prove the efficacy of a promising new treatment for atherosclerosis—the build-up of plaque in artery walls that can lead to a heart attack.

13 Sep 2011

Study shows how 9/11 attacks impacted psychological processes of those not directly exposed to the event

In the wake of the 10th Anniversary of the September 11th attacks, research published in the Journal of Traumatic Stress reveals how the attacks impacted the psychological processes of those not directly exposed to the event. The study, which focused on college students in Massachusetts, found that even those who were not directly connected to New York or Washington showed increased stress responses to run of the mill visual images.

13 Sep 2011

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

Many patients are responding to a new, minimally invasive way of treating irregular heartbeats by freezing out the bad cells. Atrial fibrillation (A-Fib) is one such heart rhythm disorder, and it's the most common arrhythmia affecting Americans.

13 Sep 2011

Medical Condition News

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

OBT, Seattle Genetics form strategic collaboration to discover novel ADCs for cancer

Genetic variant associated with increased long-term mortality risk after coronary artery bypass graft procedure

Practical NCD guide for everyone to improve their health

USU, HJF to host 'The TBI Spectrum' symposium on Sept. 22

Acceleron commences ACE-536 Phase 1 clinical trial in anemia

Henry Ford study identifies 23 microRNAs for laryngeal cancer

African-Americans have higher risk of high blood pressure earlier

High cholesterol and Alzheimer's disease

A squirt of insulin up the nose for prevention of Alzheimer’s disease

House Research Institute launches hearing loss awareness campaign

Open Access publishing likely to become preferred option for cancer researchers

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

FDA announces organizational changes within CDER's Office of Oncology Drug Products

New drug combination may treat two aggressive cancers

Delcath announces updated Phase 2 trial results from metastatic neuroendocrine tumor cohort

ADI releases World Alzheimer Report 2011

Researchers use MRI and PET/CT to assess safety, efficacy of heart drug dalcetrapib

Study shows how 9/11 attacks impacted psychological processes of those not directly exposed to the event

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News